Search results
Results from the WOW.Com Content Network
UFH is classified as Pregnancy Category C, which means animal studies have shown potential for adverse effects to the fetus; however, there needs to be more studies done to confirm the presence of a risk to the fetus. UFH can be used in pregnant women as long as the benefits outweigh the risk. [37]
Zonisamide is an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents. The precise mechanism by which zonisamide exerts its antiseizure effect is unknown, although it is believed that the drug blocks sodium and T-type calcium channels , which leads to the suppression of neuronal hypersynchronization ...
On January 12, 1989, after determining that progestogens did not cause non-genital birth defects, the FDA published a notice revising the black box warning on all progestogen drugs (except contraceptives) to warn against their use during the first four months of pregnancy because of past reports of genital birth defects (an increased risk of ...
Maternal nutrition and the avoidance of drugs, alcohol and other substances during all nine months of pregnancy (especially the critical period when the nervous system is developing) is important to the development of the fetus and its memory systems. The use of certain substances can entail long-term permanent effects on the fetus that can ...
Fetal warfarin syndrome is a disorder of the embryo which occurs in a child whose mother took the medication warfarin (brand name: Coumadin) during pregnancy.Resulting abnormalities include low birth weight, slower growth, intellectual disability, deafness, small head size, and malformed bones, cartilage, and joints.
Directly calculating the days since the beginning of the last menstrual period; Early obstetric ultrasound, comparing the size of an embryo or fetus to that of a reference group of pregnancies of known gestational age (such as calculated from last menstrual periods) and using the mean gestational age of other embryos or fetuses of the same size ...
Quickening indicates the start of fetal movements, usually felt 14–26 weeks after conception, or between the fourth and sixth month. [5] [6] A woman pregnant for the first time (i.e., a primigravida woman) typically feels fetal movements at about 20–21 weeks, whereas a woman who has given birth at least once will typically feel movements ...
Ethosuximide is usually well tolerated. [5] Common side effects include loss of appetite, abdominal pain, diarrhea, and feeling tired. [4] Serious side effects include suicidal thoughts, low blood cell levels, and lupus erythematosus. [4] [5] It is unclear if it has adverse effects on the fetus during pregnancy. [4]